Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew P. Hardy is active.

Publication


Featured researches published by Matthew P. Hardy.


Biology of Reproduction | 2002

Trends of Reproductive Hormones in Male Rats During Psychosocial Stress: Role of Glucocorticoid Metabolism in Behavioral Dominance

Matthew P. Hardy; Chantal M. Sottas; Ren-Shan Ge; Christina R. McKittrick; Kellie L.K. Tamashiro; Bruce S. McEwen; Syed G. Haider; Christopher M. Markham; Robert J. Blanchard; D. Caroline Blanchard; Randall R. Sakai

Abstract Stress in socially subordinate male rats, associated with aggressive attacks by dominant males, was studied in a group-housing context called the visible burrow system (VBS). It has been established that subordinate males have reduced serum testosterone (T) and higher corticosterone (CORT) relative to dominant and singly housed control males. The relationship of the decreased circulating T levels in subordinate males to changes in serum LH concentrations has not been evaluated previously. Since decreases in LH during stress may cause reductions in Leydig cell steroidogenic activity, the present study defined the temporal profiles of serum LH, T, and CORT in dominant and subordinate males on Days 4, 7, and 14 of a 14-day housing period in the VBS. The same parameters were followed in serum samples from single-housed control males. Leydig cells express glucocorticoid receptors and may also be targeted for direct inhibition of steroidogenesis by glucocorticoid. We hypothesize that Leydig cells are protected from inhibition by CORT at basal concentrations through oxidative inactivation of glucocorticoid by 11β-hydroxysteroid dehydrogenase (11βHSD). However, Leydig cell steroidogenesis is inhibited when 11βHSD metabolizing capacity is exceeded. Therefore, 11βHSD enzyme activity levels were measured in Leydig cells of VBS-housed males at the same time points. Significant increases in LH and T relative to control were observed in the dominant animals on Day 4, which were associated with the overt establishment of behavioral dominance as evidenced by victorious agonistic encounters. Serum LH and T were lower in subordinate males on Day 7, but T alone was lower on Day 14, suggesting that lowered LH secretion in subordinates may gradually be reversed by declines in androgen-negative feedback. Serum CORT levels were higher in subordinate males compared to control at all three time points. In contrast, oxidative 11βHSD activity in Leydig cells of dominant males was higher relative to control and unchanged in subordinates. These results suggest the following: 1) failure of Leydig cells of subordinate males to compensate for increased glucocorticoid action during stress, by increasing 11βHSD oxidative activity, potentiates stress-mediated reductions in T secretion; and 2) an inhibition of the reproductive axis in subordinate males at the level of the pituitary.


Endocrinology | 1997

Identification of a Kinetically Distinct Activity of 11β-Hydroxysteroid Dehydrogenase in Rat Leydig Cells1

Ren-Shan Ge; Hui-Bao Gao; Vijaya L. Nacharaju; Glen L. Gunsalus; Matthew P. Hardy

Leydig cells are susceptible to direct glucocorticoid-mediated inhibition of testosterone biosynthesis but can counteract the inhibition through 11β-hydroxysteroid dehydrogenase (11β-HSD), which oxidatively inactivates glucocorticoids. Of the two isoforms of 11β-HSD that have been identified, type I is an NADP(H)-dependent oxidoreductase that is relatively insensitive to inhibition by end product and carbenoxolone (CBX). The type I form has been shown to be predominantly reductive in liver parenchymal cells and other tissues. In contrast, type II, which is postulated to confer specificity in mineralocorticoid receptor (MR)-mediated responses, acts as an NAD-dependent oxidase that is potently inhibited by both end product and CBX. The identity of the 11β-HSD isoform in Leydig cells is uncertain, because the protein in this cell is recognized by an anti-type I 11β-HSD antibody, but the activity is primarily oxidative, more closely resembling type II. The goal of the present study was to determine whether th...


Proceedings of the National Academy of Sciences of the United States of America | 2008

Involvement of testicular growth factors in fetal Leydig cell aggregation after exposure to phthalate in utero.

Han Lin; Ren-Shan Ge; Guo-Rong Chen; Guo-Xin Hu; Lei Dong; Qingquan Lian; Dianne O. Hardy; Chantal M. Sottas; Xiao-Kun Li; Matthew P. Hardy

Exposures to di-(2-ethylhexyl) phthalate (DEHP) have been shown to be associated with decreased adult testosterone (T) levels and increased Leydig cell numbers. As yet, little is known about DEHP effects in utero on fetal Leydig cells (FLC). The present study investigated effects of DEHP on FLC function. Pregnant Long–Evans female rats received vehicle (corn oil) or DEHP at 10, 100, or 750 mg/kg by oral gavage from gestational day (GD)2–20. At GD21, T production, FLC numbers and distribution, and testicular gene expression were examined. The percentage of FLC clusters containing 6–30 cells increased in all treatment groups, with 29 ± 2% in control vs. 37 ± 3, 35 ± 3, and 56 ± 4% in rats receiving 10, 100, and 750 mg/kg DEHP, respectively. In contrast, FLC numbers were 33% and 39% lower than control after exposures to 100 and 750 mg/kg DEHP, respectively. At these doses, mRNA levels of leukemia inhibitory factor (LIF) increased. LIF was found to induce cell aggregation in FLCs in vitro, consistent with the hypothesis that DEHP induced FLC aggregation. Testicular T levels were doubled by the 10 mg/kg dose and halved at 750 mg/kg. The mRNA levels of IGF-1 and c-Kit ligand (KITL) were induced by 10 mg/kg DEHP. These results, taken together, indicate that fetal exposures to DEHP have effects on FLC number, distribution, and most importantly, steroidogenic capacity and suggest that abnormal expressions of IGF1, KITL, and LIF genes may contribute to the reproductive toxicity of phthalates.


Molecular and Cellular Endocrinology | 2003

Mechanisms of glucocorticoid-induced Leydig cell apoptosis

Hui-Bao Gao; Ming-Han Tong; Yan-Qin Hu; Hai-Yan You; Qiang-Su Guo; Ren-Shan Ge; Matthew P. Hardy

The high levels of corticosterone (CORT) that are typically achieved during stress induce apoptotic death of Leydig cells. The intracellular mechanisms by which CORT acts on Leydig cells to induce apoptosis are unknown, and the present study tested for mediation by Fas ligand (FasL), a member of the tumor necrosis factor ligand family, in association with caspase activation. In addition, another apoptotic pathway involving in the participation of mitochondria was studied by evaluation of mitochondrial membrane potential (DeltaPsi) loss and generation of reactive oxygen species (ROS), which are early apoptotic events in many cell types. Rat Leydig cells were isolated from adrenalectomized rats on day 90 postpartum at 3, 6, 12, 24 and 48 h after the start of CORT administration (at a dose of 5 mg total/100 g body weight per day intraperitoneally in two daily injections starting 3 days after surgery). Both FasL and Fas receptor protein levels, analyzed by Western blot and fluorescent immunohistochemistry, increased at 6 h after the start of CORT administration, peaking at 24 h and declining thereafter. Leydig cell caspase-3 activity was analyzed in vitro. Low molecular weight DNA fragments that are characteristic of apoptosis were evident in Leydig cells by 12 h of exposure to 100 nM CORT in vitro, and the abundance of the fragments was more pronounced at 24 h. In the presence of a specific caspase inhibitor, Ac-DEVD-CHO, Leydig cell apoptosis was suppressed, corroborating the hypothesis that caspase-3 is involved in CORT-mediated cell death. Western blotting analysis revealed that procaspase-3 was present only at low levels in untreated control Leydig cells, and increased by 6 h of CORT administration. By 12 h, however, procaspase-3 was significantly reduced, and the cleaved, active caspase-3 forms appeared and increased through 24 h. These results indicated that FasL/Fas and caspase were implicated in CORT-mediated Leydig cell apoptosis. Decreased DeltaPsi and increased ROS generation were also measurable in Leydig cells for up to 2 days following CORT administration in vitro. These data indicate that activation of the Fas system, cleavage of procaspase-3, loss of DeltaPsi and increased ROS generation are all implicated in the process of CORT-induced Leydig cell death.


Biology of Reproduction | 2005

Gene Expression in Rat Leydig Cells During Development from the Progenitor to Adult Stage: A Cluster Analysis

Ren Shan Ge; Qiang Dong; Chantai M. Sottas; Haolin Chen; Barry R. Zirkin; Matthew P. Hardy

Abstract The postnatal development of Leydig cells can be divided into three distinct stages: initially they exist as fibroblast-like progenitor Leydig cells (PLCs) appearing in the testis by Days 14–21; subsequently, by Day 35, they become immature Leydig cells (ILCs) acquiring steroidogenic organelle structure and enzyme activities but metabolizing most of the testosterone they produce; finally, as adult Leydig cells (ALCs) by Day 90, they actively produce testosterone. The factors controlling proliferation and differentiation of Leydig cells remain largely unknown, and the aim of the present study was to identify changes in gene expression during development through cDNA array analysis of PLCs, ILCs, and ALCs. By cluster analysis, it was determined that the transitions from PLC to ILC to ALC were associated with downregulation of mRNAs corresponding to 107 genes. The downregulated genes included cell-cycle regulators, e.g., cyclin D1 (Ccnd1); growth factors, e.g., basic fibroblast growth factor (Fgf2); growth-factor-related receptors, e.g., platelet-derived growth factor α receptor (Pdgfra); oncogenes, e.g., kit oncogene (Kit); and transcription factors, e.g., early growth response 1 (Egr1). Conversely, expression levels of 264 genes were increased by at least twofold. Most of these were related to differentiated function and included steroidogenic enzymes, e.g., 11β-hydroxysteroid dehydrogenase 2 (Hsd11b2); neurotransmitter receptors, e.g., acetylcholine receptor nicotinic α 4 (Chrna4); stress response factors, e.g., glutathione transferase 8 (Gsta4); and protein turnover enzymes, e.g., tissue inhibitor of metalloproteinase 2 (Timp2). The detection of Hsd11b2 mRNA in the array was the first indication that this gene is expressed in Leydig cells, and parallel increases in Hsd11b2 mRNA and enzyme activity were recorded. Thus, gene profiling demonstrates that postnatal development is associated with changes in the expression levels of several different clusters of genes consistent with the processes of Leydig cell growth and differentiation.


Endocrinology | 1997

Hormonal Regulation of Oxidative and Reductive Activities of 11β-Hydroxysteroid Dehydrogenase in Rat Leydig Cells1

Hui-Bao Gao; Ren-Shan Ge; Vijaya Lakshmi; Alexandru Marandici; Matthew P. Hardy

We have proposed that the 11β-hydroxysteroid dehydrogenase (11β-HSD) of Leydig cells protects against glucocorticoid-induced inhibition of testosterone (T) production. However, Leydig cells express type I 11β-HSD, which has been shown to be reductive in liver parenchymal cells. Because reduction would have the opposite effect of activating glucocorticoid, the present study was designed to determine: 1) whether Leydig cell 11β-HSD is primarily oxidative or reductive; and 2) whether oxidative and reductive activities are separately modified by known regulators of Leydig cell steroidogenic function. Leydig cells and liver parenchymal cells were purified from mature male Sprague-Dawley rats (250 g BW), and 11β-HSD oxidative and reductive activities were measured using radiolabeled substrates and TLC of triplicate media samples from 1-h incubations immediately after cell isolation. Enzyme activities also were examined in purified Leydig cells at the end of 3 days of culture in vitro in the presence of LH (10 n...


Biology of Reproduction | 2004

Development of Leydig Cells in the Insulin-Like Growth Factor-I (IGF-I) Knockout Mouse: Effects of IGF-I Replacement and Gonadotropic Stimulation

Guimin Wang; Matthew P. Hardy

Abstract Targeted gene deletion of insulin-like growth factor-I (IGF-I) results in diminished numbers of Leydig cells (LCs) and lower circulating testosterone (T) levels in adult males. The impact of endogenous IGF-I withdrawal on proliferation (labeling index, LI) and differentiation of LCs was investigated, testing for restorative effects of IGF-I replacement and/or LH stimulation. With IGF-I replacement in mutant mice, LIs increased more than 200% (P < 0.05). LC numbers were also increased by 200%, whereas the numbers of intermediate cell progenitors (PLCs) were unchanged compared to mutant vehicle controls. LIs of PLCs in wild-type males increased by 200% after LH stimulation, and LC numbers increased by 50% compared to vehicle-treated controls (P < 0.05). In contrast, there was no effect of LH on LI in mutant mice, but LC numbers still increased by 30% (P < 0.05). Additive effects on LI and cell numbers were observed in response to IGF-I plus LH in mutants, implying that the two hormones use separate signaling pathways. Serum T and LH levels in wild-type and mutant males were equivalent. Exogenous LH increased T production 8-fold in wild-type males (P < 0.01). In mutant mice, neither LH stimulation nor IGF-I alone affected serum T levels, but IGF-I plus LH stimulation increased serum T 2-fold (P < 0.05). These data support the conclusions that 1) IGF-I is a critical autocrine and/or paracrine factor in the control of adult LC numbers and function; and 2) LH is not a direct mitogenic factor for LCs, and acts in part through IGF-I to stimulate proliferative activity.


Endocrinology | 1999

Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.

Mary M. Lee; Ching Ching Seah; Peter T. Masiakos; Chantal M. Sottas; Frederic I. Preffer; Patricia K. Donahoe; David T. MacLaughlin; Matthew P. Hardy

Mullerian-inhibiting substance (MIS), a gonadal hormone in the transforming growth factor-β superfamily, induces Mullerian duct involution during male sexual differentiation. Mice with null mutations of the MIS ligand or receptor develop Leydig cell hyperplasia and neoplasia in addition to retained Mullerian ducts, whereas MIS-overexpressing transgenic mice have decreased testosterone concentrations and Leydig cell numbers. We hypothesized that MIS directly modulates Leydig cell proliferation and differentiated function in the maturing testis. Therefore, highly purified rat Leydig and Sertoli cells were isolated to examine cell-specific expression, binding, and function of the MIS type II receptor. These studies revealed that this receptor is expressed abundantly in progenitor (21-day) and immature (35-day) Leydig cells as well as in Sertoli cells. Prepubertal progenitor Leydig cells exhibit high affinity (Kd = 15 nm), saturable binding of MIS. No binding, however, is detected with either peripubertal imm...


Endocrinology | 1997

Developmental Changes in Glucocorticoid Receptor and 11β-Hydroxysteroid Dehydrogenase Oxidative and Reductive Activities in Rat Leydig Cells1

Ren-Shan Ge; Dianne O. Hardy; James F. Catterall; Matthew P. Hardy

Glucocorticoids directly regulate testosterone production in Leydig cells through a glucocorticoid receptor (GR)-mediated repression of the genes that encode testosterone biosynthetic enzymes. The extent of this action is determined by the numbers of GR within the Leydig cell, the intracellular concentration of glucocorticoid, and 11β-hydroxysteroid dehydrogenase (11βHSD) activities that interconvert corticosterone (in the rat) and its biologically inert derivative, 11-dehydrocorticosterone. As glucocorticoid levels remain stable during pubertal development, GR numbers and 11βHSD activities are the primary determinants of glucocorticoid action. Therefore, in the present study, levels of GR and 11βHSD messenger RNA (mRNA) and protein were measured in rat Leydig cells at three stages of pubertal differentiation: mesenchymal-like progenitors (PLC) on day 21, immature Leydig cells (ILC) that secrete 5α-reduced androgens on day 35, and adult Leydig cells (ALC) that are fully capable of testosterone biosynthesi...


Archive | 2007

Regulation of Leydig Cells During Pubertal Development

Ren-Shan Ge; Matthew P. Hardy

Adult Leydig cells are terminally differentiated cells with an organelle structure adapted to serve in steroidogenesis. Adult Leydig cells are formed during pubertal development from a precursor cell population, through a series of intermediate stages beginning ultimately with a stem cell designated as a stem Leydig cell. The stem Leydig cells are distributed in the interstitial space and might be centrally located or adjacent to peritubular cells that sit immediately atop the basal lamina of the seminiferous tubule, or to blood vessels. The ultimate origin of stem Leydig cells remains a topic of active research, with most investigators favoring mesenchymal cells derived from the primitive kidney (mesonephros), but others supporting sources including the neural crest and coelomic epithelium, which later give rise to the tunica (testis capsule). Although it is firmly established that luteinizing hormone (LH) is the chief tropic stimulus of Leydig cell steroidogenesis, the process by which stem Leydig cells acquire the ability to respond to hormone stimulation is largely unknown. Growth factors produced locally by Sertoli cells, including Desert Hedgehog, plateletderived growth factor, leukemia inhibitory factor, Kit ligand and insulin-like growth factor-1, may act sequentially or together to stimulate the transition from stem to later stage Leydig cell before LH sensitivity is acquired. Androgen, potentially secreted by fetal Leydig cells may be essential for initial development of adult Leydig cells. LH signaling is necessary to amplify cell numbers further and induce the differentiation of later stage Leydig cell intermediates. Puberty concludes with the creation, in the testis of the adult rat, of a population of about 25 million Leydig cells that produce testosterone.

Collaboration


Dive into the Matthew P. Hardy's collaboration.

Top Co-Authors

Avatar

Ren-Shan Ge

Wenzhou Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Han Lin

Rockefeller University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Guo-Xin Hu

Wenzhou Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge